Philosophy of Care

It is critical to offer the most advanced evidence-based options for patients with gynecologic cancers, but perhaps more important is fostering a doctor-patient relationship that allows a care plan sensitive to the individual needs of my patients. I feel privileged to work at MN Oncology, which offers cutting-edge care and research in a comfortable setting close to home.

About

Research/Publications

Bradley A, Zheng H, Ziebarth AJ, Sakati W, Branham-O'Connor M, Blumer JB, Liu Y, Kistner-Griffin E, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Landen CN Jr, Eblen ST. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014. PMID: 24379240

Ziebarth AJ, Felder MA, Harter J, Connor JP. Uterine leiomyosarcoma diffusely expresses disialoganglioside GD2 and binds the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy. Cancer Immunol Immunotherapy. 2012, May 6. PMID 22562378

Ziebarth AJ, Nowsheen S, Steg AD, Shah MM, Dobbin ZC, Han HD, Lopez-Berestein G, Sood AK, Conner MB, Yang ES, Landen CN Jr Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer. Clin Cancer Res. 2012, Nov 12. PMID 23147994

Steg AD, Katre AA, Bevis KS, Ziebarth AJ, Dobbin ZC, Shah MM, Alvarez RD, Landen CN. Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer. Molecular Cancer Therapeutics. 2012, May 2. PMID 22553355

Ziebarth AJ, Smith H, Killian ME, Nguyen NA, Durst JK, Subramaniam A, Kim KH, Leath CA 3rd, Straughn JM Jr, Alvarez RD. Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy. Gynecol Oncol. Accepted 2012, Apr 5. PMID 22484400

Ziebarth AJ, Landen CN Jr, Alvarez RD. Molecular/Genetic therapies in ovarian cancer: future opportunities and challenges. Clin Obstet Gynecol. 2012 Mar;55(1):156-72. PMID 22343235

Steg AD, Bevis KS, Katre AA, Ziebarth AJ, Dobbin ZC, Alvarez RD, Zhang K, Conner M, Landen CN.Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Canc Research. 2012, Feb 1;18(3):869-81. PMID 22142828

Ziebarth AJ, Eyster K, Hansen K. Delayed Diagnosis of a Partially Obstructed Longitudinal Vaginal Septum. Fertil Steril. 2007. Mar;87(3):697.e17-20. PMID 17140575

Ziebarth AJ, Hansen KA. Hormonal Emergency Contraception: a clinical primer. SD Med. 2007, Mar;60(3):99-105. PMID 17455578 

Board Certification

• Board Certified in Gynecology Oncology
• Board Certified in Obstetrics and Gynecology

Affiliations

• Society of Gynecologic Oncologists
• American College of Obstetrics and Gynecology (FACOG)
• Alpha Omega Alpha Honor Medical Society

Originally from South Dakota, Dr. Ziebarth attended Gustavus Adolphus College in St. Peter, MN.  She completed Medical School at the University of South Dakota then completed her residency in Obstetrics and Gynecology as Chief Resident at the University of Wisconsin.  Subsequently she pursued an additional 3 year boarded fellowship in Gynecologic Oncology at the University of Alabama at Birmingham.  Following this she served as faculty at Florida State University and at the University of Florida Residency Program in Pensacola, where her husband, an officer in Air Force Special Operations, was stationed. 

She is delighted to return to Minnesota. In her spare time, Dr. Ziebarth enjoys time with her husband and children, making music, and being outdoors.